Article (Scientific journals)
Le medicament du mois. Le tiotropium (SPIRIVA)
Corhay, Jean-Louis; Louis, Renaud
2004In Revue Médicale de Liège, 59 (9), p. 530-3
Peer reviewed
 

Files


Full Text
Le médicament du mois_Le tiotropium (Spiriva)_Corhay_04_RevMedLg.pdf
Publisher postprint (480.39 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] SPIRIVA (tiotropium) is a long-acting anticholinergic bronchodilatator, inhaled once a day, which produces relaxation of airway smooth muscle through antagonism of acetylcholine at M3-muscarinic receptors. Its duration of action is at least 24h with once daily administration of tiotropium. Several studies have shown its efficacy and its good tolerance in the treatment of patients who are suffering from moderate to very severe chronic obstructive pulmonary disease (COPD). SPIRIVA improves spirometric measurements and quality of life, and reduces dyspnea and exacerbation rate in COPD patients.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Corhay, Jean-Louis ;  Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Louis, Renaud ;  Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Language :
French
Title :
Le medicament du mois. Le tiotropium (SPIRIVA)
Publication date :
September 2004
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
59
Issue :
9
Pages :
530-3
Peer reviewed :
Peer reviewed
Available on ORBi :
since 17 March 2009

Statistics


Number of views
284 (0 by ULiège)
Number of downloads
246 (2 by ULiège)

Scopus citations®
 
5
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi